Complement C1r serine protease contributes to kidney fibrosis
- 1 November 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 317 (5) , F1293-F1304
Abstract
We have previously reported that complement activation precedes the development of kidney fibrosis; however, little is known about the cellular mechanisms involved in this transition. We hypothesized that increased expression of C1 complex protease C1r, the initiator of complement activation, contributes to tubulointerstitial fibrosis and tested this idea in mice with global deletion of C1r. Although expression of C1r in untreated wild-type (WT) mice was higher in the liver compared with kidney tissue, administration of folic acid (FA) led to upregulation of C1r mRNA and protein levels only in kidney tissue. Immunohistochemistry and in situ hybridization experiments localized increased expression of C1r and C1s proteases to renal tubular epithelial cells. C1r-null mice had reduced acute tubular injury and inflammation measured 2 days after FA administration compared with WT mice. C1r deletion reduced expression of C1s, C3 fragment formation, and organ fibrosis measured 14 days after FA administration. Differential gene expression performed in kidney tissue demonstrated that C1r-null mice had reduced expression of genes associated with the acute phase response, complement, proliferation of connective tissue cells (e.g., platelet-derived growth factor receptor-β), and reduced expression of genes associated with inflammation compared with FA-treated WT mice. In vitro experiments in renal epithelial cells demonstrated that C1s expression is dependent on increased C1r expression and that interferon-γ induces the expression of these two proteases. We conclude that increased expression of C1 complex proteases is associated with increased tissue inflammation and complement C3 formation and represents an important pathogenic mechanism leading to FA-mediated tubulointerstitial fibrosis.Keywords
Funding Information
- NIDDK (RO1DK75976)
- VA Merit
This publication has 35 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Complement in Immune and Inflammatory Disorders: Therapeutic InterventionsThe Journal of Immunology, 2013
- Gene expression databases for kidney epithelial cellsAmerican Journal of Physiology-Renal Physiology, 2012
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic PathwaysScience Translational Medicine, 2012
- Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implicationsJournal of Translational Medicine, 2011
- IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1Journal of Investigative Dermatology, 2007
- Progression of chronic kidney disease: Can it be prevented or arrested?The American Journal of Medicine, 2005
- Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassaysMolecular Immunology, 2004
- Assembly and Enzymatic Properties of the Catalytic Domain of Human Complement Protease C1rJournal of Biological Chemistry, 2001
- Structure and Assembly of the Catalytic Region of Human Complement Protease C1̄r: A Three-Dimensional Model Based on Chemical Cross-Linking and Homology ModelingBiochemistry, 1997